Monica Chen, Joseph Tsai, 3 September 2012
Intel may be forced to adjust its roadmap for PC-use Atom processors
as the top-2 netbook vendors – Asustek Computer and Acer – both plan to stop
manufacturing related products, according to sources from notebook players.
Asustek is already set to halt its Eee PC product line and
officially phase out from the IT industry after completely digesting any
remaining inventory. As for Acer, so far, the company has not yet made any plans
to open new netbook projects, indicating that the vendor may also plan to step
out of the market.
Although Atom series processors will still be adopted by handset and
embedded products, the sources believe the two product lines are unlikely to be
able to fill the gap created by the absent netbook products in short term due to
weak shipments.
Asustek CEO Jerry Shen recently confirmed that the company will stop
production of Eee PC netbooks using Atom-based processors such as the N2600 due
to impact from tablet PCs and notebooks, as well as a sharp drop in demand in
emerging markets. Asustek plans to have its Transformer tablet PCs fill the
10-inch mobile device market, replacing its netbook product line.
Micro-Star International (MSI), which is selling a small volume of
Atom N2800-based products, also has no plans to continue shipping related
products.
Although netbook vendors were originally optimistic about demand
from Southeast Asia, Latin America and Middle East regions, as tablet PCs are
rising quickly and many government procurement orders have turned to tablet PC
products instead, demand for 10-inch netbooks has dropped rapidly, accelerating
the segment's exit from the IT market.
In addition, Windows 8's licensing fees, and upgrades in panels to
higher resolutions and touchscreen functions will all add to netbook costs
forcing netbook vendors to give up the product line before entering the Windows
8 generation.
Dropping netbook orders are also expected to affect shipments of
netbook ODMs Pegatron Technology and Compal Electronics.
No comments:
Post a Comment